5.83

8.92% 0.48

Edesa Biotech Inc (EDSA)

Overview News Price History Financials Discussions Forecast Stock Split

Edesa Biotech Inc stock is traded at $5.83, with a volume of 114.77K. It is up +8.92% in the last 24 hours and down -11.71% over the past month. Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Previous Close:

$5.35

Open:

$5.36

24h Volume:

114.77K

Relative Volume:

0.69

Market Cap:

$55.87M

Revenue:

Net Income/Loss:

$-10.44M

P/E Ratio:

-4.3488

EPS:

-1.3406

Net Cash Flow:

$-7.72M

1W Performance:

+11.20%

1M Performance:

-11.71%

6M Performance:

+468.49%

1Y Performance:

+160.72%

1-Day Range:

$5.36

$6.67

1-Week Range:

$5.25

$6.67

52-Week Range:

$0.72

$20.32

Edesa Biotech Inc Stock (EDSA) Company Profile

Name

Edesa Biotech Inc

Sector

Healthcare (1089)

Industry

Biotechnology (604)

Phone

(905) 475-1234

Address

100 SPY COURT, MARKHAM, ON

Employee

Twitter

@EdesaBiotech

Next Earnings Date

2026-08-14

Latest SEC Filings

EDSA's Discussions on Twitter

Compare EDSA vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
EDSA Edesa Biotech Inc	5.80	51.54M	0	-10.44M	-7.72M	-1.3406
VRTX Vertex Pharmaceuticals Inc	515.44	128.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	806.90	82.72B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	992.82	53.26B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	215.68	43.66B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	362.27	39.31B	5.76B	514.49M	1.10B	4.4813

Edesa Biotech Inc Stock (EDSA) Latest News

Aug 14, 2026

EDSA Stock Soars More Than 700% So Far This Year: Wall Street Eyes Further Upside In Run Up To Acute Kidney Injury Data Reveal - Stocktwits

Aug 14, 2026

EDSA Stock Rallied Over 50% Today: What’s Ahead For The Small-Cap Biotech? - Stocktwits

Aug 14, 2026

Aug 13, 2026

Edesa Biotech (NASDAQ:EDSA) Posts Earnings Results, Misses Expectations By $0.16 EPS - MarketBeat

Aug 13, 2026

Edesa Biotech Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 13, 2026

Form 8K EDESA BIOTECH For: 13 August By Investing.com - Investing.com South Africa

Aug 13, 2026

Edesa Biotech Q3 loss widens 140% to $5.4M on rising R&D spend - scanx.trade

Aug 13, 2026

Edesa Biotech (EDSA) loss widens to $11.9M as R&D surges and cash tightens - Stock Titan

Aug 13, 2026

Edesa Reports $5.4 Million Q3 Loss as EB06 Phase 2 Site Activation Begins - Quiver Quantitative

Aug 13, 2026

Edesa Starts Activating First Vitiligo Trial Sites as Enrollment Nears - Stock Titan

Aug 13, 2026

Aug 11, 2026

Edesa Biotech Inc expected to post a loss of 58 cents a shareEarnings Preview - TradingView

Aug 11, 2026

Aug 10, 2026

Why Did EDSA Stock Rally More Than 70% Today? - Stocktwits

Aug 10, 2026

Aug 09, 2026

Edesa Biotech (EDSA) to Post Earnings on Monday - MarketBeat

Aug 09, 2026